BBIO
BridgeBio Pharma Inc

5,301
Loading...
Loading...
BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
730

Frequently Asked Questions

What is Market Cap of BridgeBio Pharma Inc?
What is the 52-week high for BridgeBio Pharma Inc?
What is the 52-week low for BridgeBio Pharma Inc?
What is BridgeBio Pharma Inc stock price today?
What was BridgeBio Pharma Inc stock price yesterday?
What is the PE ratio of BridgeBio Pharma Inc?
What is the Price-to-Book ratio of BridgeBio Pharma Inc?
What is the 50-day moving average of BridgeBio Pharma Inc?
How many employess does BridgeBio Pharma Inc has?

Latest BBIO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.